scholarly journals PRIVATIZATION EFFICACY FINANCIAL ANALYSIS AND THE CURRENT SITUATION OF THE PHARMACEUTICAL INDUSTRY IN SERBIA

2018 ◽  
Author(s):  
Nikola Vidović ◽  
◽  
Milenko Dželetović ◽  
Olga Zorić ◽  
◽  
...  
Keyword(s):  
Pharmaceutical Industry ◽  
Financial Analysis ◽  
Current Situation

Traceability without uncertainty: current situation in the pharmaceutical industry

2003 ◽  
Vol 8 (11) ◽  
pp. 530-531 ◽  
Author(s):  
Ilya Kuselman ◽  
Alexander Weisman ◽  
Wolfhard Wegscheider
Keyword(s):  
Pharmaceutical Industry ◽  
Current Situation

EARLY DIALOGUE IN EUROPE: PERSPECTIVES ON VALUE, CHALLENGES, AND CONTINUING EVOLUTION

2018 ◽  
Vol 34 (5) ◽  
pp. 514-518 ◽  
Author(s):  
Lina Balaisyte ◽  
Angelika Joos ◽  
Mickaël Hiligsmann
Keyword(s):  
Pharmaceutical Industry ◽  
Development Program ◽  
Health Technology ◽  
Current Situation ◽  
European Medicines Agency ◽  
Pharmaceutical Companies ◽  
Future Perspectives ◽  
Structured Interviews ◽  
Dialogue Process ◽  
Axial Coding

Objectives:This study aims to assess participants’ views on previous experiences, the current situation and future perspectives for early dialogue between the pharmaceutical industry, a regulatory agency and health technology assessment bodies (HTABs) in Europe.Methods:Eleven semi-structured interviews were arranged purposively with experienced people from the pharmaceutical industry, the European Medicines Agency, and an expert in Health Economics. The interview questions focused on the value of early dialogue, the challenges faced during the process of early dialogue, the best time to start an early dialogue, the kind of products most suitable for early dialogue, the current situation, and future perspectives for the early dialogue process. The interviews were recorded and then transcribed for open and axial coding to summarize the findings.Results:All interviewees agreed that early dialogue is a valuable process that helps to inform the development program and accordingly provide patients with faster access to new medicines. However, at this stage, the pharmaceutical industry acknowledged certain challenges: (i) Finding resources within pharmaceutical companies and HTABs to support early dialogues (ii) Requirements between regulators and HTABs in different countries diverge.Conclusions:This study revealed that people from the pharmaceutical industry perceive early dialogue as a valuable tool that can bring medicines to patients faster by streamlining development. However, the challenges mentioned above need to be mitigated to build a sustainable mechanism for early dialogue.

scholarly journals Market Research of Nutrition and Healthcare Products Industry in China

2021 ◽  
Vol 7 (3) ◽  
pp. p26
Author(s):  
Bing Ma ◽  
Margaret Ma
Keyword(s):  
Pharmaceutical Industry ◽  
Market Research ◽  
Current Situation ◽  
Marketing Management ◽  
Nutrition And Health ◽  
Market Segments ◽  
Existing Problems ◽  
Marketing Models ◽  
Health Products ◽  
Fierce Competition

The nutrition and healthcare products industry is the largest health industry in China except the pharmaceutical industry. Optimistic market prospects, attractive product profits make enterprises face fierce competition, and market research on this industry is imperative. Based on the current situation of the market of the nutrition and healthcare products industry in China and the existing problems in marketing management, this paper analyzes the nutrition and healthcare products market segments and marketing models, also puts forward some suggestions on the development of the nutrition and health products business from the macro and micro levels.

scholarly journals Medicines development and regulation in Africa

2015 ◽  
Vol 1 (2) ◽  
pp. 33
Author(s):  
Bernd Rosenkranz ◽  
Michael Reid ◽  
Elizabeth Allen
Keyword(s):  
Clinical Trials ◽  
Pharmaceutical Industry ◽  
Education And Training ◽  
Training Needs ◽  
Current Situation ◽  
Pharmaceutical Companies ◽  
Local Companies ◽  
Economic Regions ◽  
Development Regulation ◽  
And Training

Africa is one of the world’s fastest-growing economic regions, with a rise in its pharmaceutical industry value from $4.7 billion in 2003 to $20.8 billion in 2013. Multinational pharmaceutical companies are becoming more active in drug production and clinical trials across Africa, and there is an increase in the number of local companies engaged in medicines development and marketing. Such expansion of the local pharmaceutical industry requires trained pharmaceutical specialists to support it. The current situation and future requirements for local medicines development, regulation, education and training needs are discussed.

Global Pharmaceutical Industry

2019 ◽  
pp. 57-85
Author(s):  
Agnieszka Szmelter
Keyword(s):  
Developing Countries ◽  
Pharmaceutical Industry ◽  
Healthcare Systems ◽  
Global Market ◽  
Current Situation ◽  
The Other ◽  
Economic Environment ◽  
Market Forces ◽  
Research Results ◽  
The Right

The pharmaceutical industry is seen as one of the most dynamic, volatile, and innovative parts of the global economic environment. It also has a big impact on the society and is an indicator of the healthcare systems' condition. Some changes have happened in the last decades, for example, shifting the production facilities to the developing countries, new market entries, or the new law changed the previously established and stable layout of market forces. The chapter aims at presenting the current situation of the global pharmaceutical industry including the main trends influencing the changes in this sector. Describing this part of the global market will ensure the right interpretation of the research results of the other parts of the book.

Sign in / Sign up

Export Citation Format

Share Document